...
机译:SARS-COV-2设计蛋白纳米颗粒疫苗诱导有效的中和抗体应答
Univ Washington Dept Biochem Seattle WA 98195 USA;
Univ Washington Dept Biochem Seattle WA 98195 USA;
Univ N Carolina Dept Epidemiol Chapel Hill NC 27514 USA;
Univ Washington Dept Biochem Seattle WA 98195 USA;
Univ Washington Dept Biochem Seattle WA 98195 USA;
Univ Washington Dept Biochem Seattle WA 98195 USA;
Univ N Carolina Dept Epidemiol Chapel Hill NC 27514 USA;
Univ Washington Dept Immunol Seattle WA 98109 USA;
Univ Washington Dept Microbiol Seattle WA 98109 USA;
Univ Washington Dept Med Chem Seattle WA 98195 USA;
Univ Washington Dept Biochem Seattle WA 98195 USA;
Univ Washington Dept Biochem Seattle WA 98195 USA;
Univ Washington Dept Biochem Seattle WA 98195 USA;
Univ Washington Dept Biochem Seattle WA 98195 USA;
Univ Washington Dept Biochem Seattle WA 98195 USA;
Univ Washington Dept Biochem Seattle WA 98195 USA;
Kymab Ltd Babraham Res Campus Cambridge England;
Kymab Ltd Babraham Res Campus Cambridge England;
Kymab Ltd Babraham Res Campus Cambridge England;
Univ Washington Dept Microbiol Seattle WA 98109 USA;
Univ Washington Dept Biochem Seattle WA 98195 USA;
Univ Washington Dept Biochem Seattle WA 98195 USA;
Univ Washington Dept Biochem Seattle WA 98195 USA;
Univ Washington Dept Med Chem Seattle WA 98195 USA;
Univ Washington Dept Microbiol Seattle WA 98109 USA;
Univ Washington Dept Microbiol Seattle WA 98109 USA;
Univ N Carolina Dept Microbiol &
Immunol Chapel Hill NC 27514 USA;
Univ N Carolina Dept Epidemiol Chapel Hill NC 27514 USA;
Univ N Carolina Dept Epidemiol Chapel Hill NC 27514 USA;
Univ N Carolina Dept Epidemiol Chapel Hill NC 27514 USA;
Univ Washington Dept Microbiol Seattle WA 98109 USA;
Univ Washington Dept Med Chem Seattle WA 98195 USA;
Univ Washington Dept Med Seattle WA 98109 USA;
Univ Washington Dept Med Chem Seattle WA 98195 USA;
Univ Washington Dept Microbiol Seattle WA 98109 USA;
Univ N Carolina Dept Epidemiol Chapel Hill NC 27514 USA;
Kymab Ltd Babraham Res Campus Cambridge England;
Univ Washington Dept Biochem Seattle WA 98195 USA;
Univ Washington Dept Immunol Seattle WA 98109 USA;
Univ N Carolina Dept Epidemiol Chapel Hill NC 27514 USA;
Univ Washington Dept Biochem Seattle WA 98195 USA;
Univ Washington Dept Biochem Seattle WA 98195 USA;
机译:由设计的蛋白纳米颗粒疫苗诱导有效的中和抗体应答呼吸合胞病毒
机译:用自组装纳米颗粒疫苗免疫引发有效的中和抗体反应对EBV感染的抗体反应
机译:通过小鼠的SARS-COV-2尖峰受体结合结构域FC融合蛋白增强效力中和抗体的诱导
机译:融合构象中的结构限制型流感亚种疫苗,可能产生中性抗体反应
机译:强效中和性单克隆抗体1B7:其独特的表位,对细胞内运输有影响,并在感染百日咳后诱发。
机译:SARS-COV-2的设计蛋白纳米颗粒疫苗诱导有效的中和抗体应答
机译:汉坦/安第斯山脉病毒DNa疫苗在非人类灵长类动物中引发广泛的交叉反应中和抗体反应